Research center scores $20M NIH grant for HIV drug development

07/13/2011 | Seattle Times, The

The NIH has awarded a five-year grant worth $20 million to researchers at the Fred Hutchinson Cancer Research Center in Seattle to develop a treatment for HIV. Scientists at the research center are testing an approach in which they genetically alter an HIV-positive patient's cells to make them resistant to the virus.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC